265 related articles for article (PubMed ID: 17430797)
21. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
22. Medical treatment of connective tissue disease.
Ciavaglia SJ; Costello PB; Panara N
Ear Nose Throat J; 1987 Nov; 66(11):457-62. PubMed ID: 3443075
[No Abstract] [Full Text] [Related]
23. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
[TBL] [Abstract][Full Text] [Related]
24. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
25. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
Rosenthal M
J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
[TBL] [Abstract][Full Text] [Related]
26. [Lung and autoimmune disease--therapy].
Hauber HP; Zabel P
Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
[TBL] [Abstract][Full Text] [Related]
27. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
Wolfe RM; Ang DC
Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
[TBL] [Abstract][Full Text] [Related]
28. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Sfikakis PP
Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
[TBL] [Abstract][Full Text] [Related]
29. The immunology of rheumatoid diseases.
Koffler D
Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
[No Abstract] [Full Text] [Related]
30. B cell depletion therapy in rheumatic disease.
Edwards JC; Cambridge G; Leandro MJ
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
[TBL] [Abstract][Full Text] [Related]
31. Biological therapies of autoimmune diseases.
Kourbeti IS; Boumpas DT
Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):41-6. PubMed ID: 15720235
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of etanercept in chronic immune-mediated disease.
Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
[TBL] [Abstract][Full Text] [Related]
33. Cellular targeting in autoimmunity.
Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
[TBL] [Abstract][Full Text] [Related]
34. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
Kato M; Yasuda S; Atsumi T
Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
[TBL] [Abstract][Full Text] [Related]
35. Anti-cytokine antibodies for rheumatic diseases.
Atzeni F; Sarzi-Puttini P
Curr Opin Investig Drugs; 2009 Nov; 10(11):1204-11. PubMed ID: 19876788
[TBL] [Abstract][Full Text] [Related]
36. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.
Atzeni F; Sarzi-Puttini P; Doria A; Iaccarino L; Capsoni F
Autoimmun Rev; 2005 Mar; 4(3):144-52. PubMed ID: 15823500
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
